RE: More detail emerge of the fundraise6 Jan 2023 16:28
Got to say, the retail total was very disappointing =~( However the directors have stumped up a few quid in the placing =~)
The corporate team at Penningtons Manches Cooper has advised SkinBioTherapeutics plc (AIM: SBTX) on a £2.5 million placing, and a separate retail offer to existing shareholders through the REX platform, raising an additional £117,378.